Vensica Medical

About

Headcount over time

Offices

Q&A

What is Vensica Medical's primary focus?

Vensica Medical is a clinical-stage biotechnology company that develops needle-free therapeutic delivery solutions for urologic diseases, utilizing its proprietary Vibe® platform for localized drug delivery into the bladder wall.

When was Vensica Medical founded?

Vensica Medical was founded in 2014.

How many employees does Vensica Medical currently have?

Vensica Medical has 11-50 employees.

What was Vensica Medical's most recent funding round?

Key investors included Israel Biotech Fund (IBF), Merz, and Laborie.

Which investors participated in Vensica Medical's B Round in November 2021?

The B Round in November 2021 included investments from Israel Biotech Fund (IBF) and Laborie.

What is Vensica Medical's lead product program?

Vensica Medical's lead program, ViXe, combines the Vibe system with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB).

What was the amount raised in Vensica Medical's B Round in February 2022?

In February 2022, Vensica Medical raised $20,000,000 in a B Round, with.

What is the core technology behind Vensica Medical's drug delivery system?

Vensica Medical's Vibe® platform uses focused ultrasound to enable localized delivery of biologic and small-molecule drugs into the bladder wall.

Team · 8

Avner Geva

Founder · CEO, Cofounder

Avi Eftel

Founder · CTO, Cofounder

Roger R. Dmochowski, MD

CMO

Ken Berlin

Executive Chairman of the Board

Ido Zairi

Board Member

Tami Abudi

VP Clinical and Regulatory Affairs

Howard Goldman, MD

Professor of Urology, Cleveland Clinic (Scientific Advisory Board)

Dr. Michael Weinrib

Professor of Urology, Meir Medical Center (Scientific Advisory Board)

Sectors & technology

Highlights

Tags